Anti-TRPM1 antibodies in patients with retinal degeneration

Clin Exp Ophthalmol. 2018 Dec;46(9):1087-1089. doi: 10.1111/ceo.13341. Epub 2018 Jul 1.

Authors

Koji M Nishiguchi¹, Kosuke Fujita², Takashi Inoue³, Toru Nakazawa^{1

2

4}

Affiliations

¹ Department of Advanced Ophthalmic Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
² Department of Retinal Disease Control, Tohoku University Graduate School of Medicine, Sendai, Japan.
³ Department of Marmoset Research, Central Institute for Experimental Animals, Kawasaki, Japan.
⁴ Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan.

PMID: 29927037
DOI: 10.1111/ceo.13341

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Autoantibodies / immunology*
Blotting, Western
Electroretinography
Humans
Male
Middle Aged
Retinal Bipolar Cells / pathology*
Retinal Degeneration / diagnosis
Retinal Degeneration / immunology*
Retinal Degeneration / metabolism
TRPM Cation Channels / immunology*
TRPM Cation Channels / metabolism
Tomography, Optical Coherence
Visual Acuity*

Substances

Autoantibodies
TRPM Cation Channels
TRPM1 protein, human